Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 26, 2021 - Issue 1
Submit an article Journal homepage
344
Views
5
CrossRef citations to date
0
Altmetric
Review

Emerging topical drugs for the treatment of rosacea

Federica Dall’OglioDermatology Clinic, University of Catania, Catania, ItalyView further author information
,
Maria Rita NascaDermatology Clinic, University of Catania, Catania, ItalyView further author information
&
Giuseppe MicaliDermatology Clinic, University of Catania, Catania, ItalyCorrespondence[email protected]
View further author information
Pages 27-38 | Received 24 Sep 2020, Accepted 03 Feb 2021, Published online: 18 Feb 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kristen Delans, Katherine Kelly & Steven R. Feldman. (2022) Treatment strategies, including antibiotics, to target the immune component of rosacea. Expert Review of Clinical Immunology 18:12, pages 1239-1251.
Read now
Federica Dall’Oglio, Maria Rita Nasca, Carlo Gerbino & Giuseppe Micali. (2022) Advances in pharmacotherapy for rosacea: what is the current state of the art?. Expert Opinion on Pharmacotherapy 23:16, pages 1845-1854.
Read now

Articles from other publishers (3)

Madeleine ANDREAS, Anna FABCZAK-KUBICKA & Robert A. SCHWARTZ. (2023) Ocular rosacea: an under-recognized entity. Italian Journal of Dermatology and Venereology 158:2.
Crossref
JingYu Wang, Yan Sun, LiangHong Chen, YiChong Wang, DongXin Shi, Yan Wu & XingHua Gao. (2023) Supramolecular salicylic acid ameliorates rosacea-like eruptions by suppressing NLRP3-mediated inflammasome activation in mice. International Immunopharmacology 118, pages 110057.
Crossref
Viktoriia Frolova, Olga Glinkina & Tatyana Shpilkina. (2021) Financial Risks and their Management in the Mining Industry. E3S Web of Conferences 278, pages 03041.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.